🇺🇸 FDA
Patent

US 7704491

Recombinant human metapneumovirus and its use

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 7704491 (Recombinant human metapneumovirus and its use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/70, A61K39/12